Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Der Urologe. Ausg. A
|
December 15, 2010
[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?]
T Szarvas, F Hoffmann, M Becker, et al.
Der Urologe. Ausg. A
|
April 16, 2004
[Inhaled immunotherapy for pulmonary metastases of renal cell cancer]
G Lümmen, M Schenck, C Börgermann, et al.
Der Urologe. Ausg. A
|
December 3, 2008
[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder]
F vom Dorp, C Börgermann, M Schenck, et al.
Der Urologe. Ausg. A
|
March 16, 2007
[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta]
M Schenck, C Börgermann, T Jäger, et al.
Der Urologe. Ausg. A
|
June 27, 2007
[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer]
T Jäger, T Szarvas, F vom Dorp, et al.
Der Urologe. Ausg. A
|
July 6, 2006
[Urinary cytology. Possibilities, limitations and the future]
D Zaak, S Tritschler, R Knuechel, et al.
Der Urologe. Ausg. A
|
July 31, 2007
[Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1]
R Rossi, T Jaeger, C Börgermann, et al.
Der Urologe. Ausg. A
|
July 21, 2007
[Urinary tract tumor registry]
F vom Dorp, C Börgermann, P J Goebell, et al.
British Journal of Pharmacology
|
July 24, 2010
Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells
A Rose, M Grandoch, F vom Dorp, et al.
Der Urologe. Ausg. A
|
June 30, 2018
[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]
M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Der Urologe. Ausg. A
|
December 15, 2010
[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?]
T Szarvas, F Hoffmann, M Becker, et al.
Der Urologe. Ausg. A
|
April 16, 2004
[Inhaled immunotherapy for pulmonary metastases of renal cell cancer]
G Lümmen, M Schenck, C Börgermann, et al.
Der Urologe. Ausg. A
|
December 3, 2008
[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder]
F vom Dorp, C Börgermann, M Schenck, et al.
Der Urologe. Ausg. A
|
March 16, 2007
[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta]
M Schenck, C Börgermann, T Jäger, et al.
Der Urologe. Ausg. A
|
June 27, 2007
[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer]
T Jäger, T Szarvas, F vom Dorp, et al.
Der Urologe. Ausg. A
|
July 6, 2006
[Urinary cytology. Possibilities, limitations and the future]
D Zaak, S Tritschler, R Knuechel, et al.
Der Urologe. Ausg. A
|
July 31, 2007
[Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1]
R Rossi, T Jaeger, C Börgermann, et al.
Der Urologe. Ausg. A
|
July 21, 2007
[Urinary tract tumor registry]
F vom Dorp, C Börgermann, P J Goebell, et al.
British Journal of Pharmacology
|
July 24, 2010
Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells
A Rose, M Grandoch, F vom Dorp, et al.
Der Urologe. Ausg. A
|
June 30, 2018
[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]
M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Page
of 6